Professor Alan Emery | |
---|---|
Born | Alan Eglin Heathcote Emery 1928 (age 96–97) |
Education | University of Manchester, Johns Hopkins University (Ph.D.) |
Occupation | Medical genetics |
Known for | Emery–Dreifuss muscular dystrophy and its defective protein product, emerin |
Scientific career | |
Institutions | University of Edinburgh, Green Templeton College, Oxford |
Alan Eglin Heathcote Emery FRCP , FRCPE ,, FLS , FRSA , FRSE (born August 21, 1928) is a British medical geneticist, known for his study of muscular dystrophy.
Emery began his working life in the King's Hussars, [1] and graduated in biological sciences from University of Manchester. [1] In 1960 he obtained his medical degree there. [1] [2]
His PhD in human genetics was earned at Johns Hopkins University. [1] [2]
In 1968 he became a foundation professor of human genetics at the University of Edinburgh. [1]
Having established the European Neuromuscular Centre, he was its chief scientific advisor from 1999. [1]
He was the first president of the Royal Society of Medicine’s Section of Medical Genetics, which he established, from 2001 to 2004. [1]
He was a research fellow and subsequently an honorary fellow of Green Templeton College from 1985. [1]
He was elected a Fellow of the Royal College of Physicians (FRCP), Fellow of the Royal College of Physicians of Edinburgh (FRCPE), a Fellow of the American College of Medical Genetics (FACMG), a Fellow of the Linnean Society (FLS), a Fellow of the Royal Society of Arts (FRSA) and a Fellow of the Royal Society of Edinburgh (FRSE). [1]
Both Emery–Dreifuss muscular dystrophy and its first known defective protein product, emerin, are named after him (the former jointly with Fritz E. Dreifuss)). [1]